Answers are grounded in this paper and cite their sources.
This study examines whether the 2023–2025 financial statements of PT Medco Energi Internasional Tbk (MEDC) allow the forward element of cash flow hedges to be traced numerically from derivative instruments through other comprehensive income (OCI) and the hedging reserve to profit or loss. A single-case document analysis built a six-stage accounting trail and assessed each stage under a conservative criterion that never treats aggregate figures as proxies for the forward element. MEDC states consistently over the three years that only the spot element is designated as the hedging instrument and that the forward element is recognised in OCI, and instrument-level information is available. However, OCI and the reserve appear only in aggregate, the statement of changes in equity carries a single hedging column, and no amount is attributed to the forward element or its reclassification. The reserve (parent-attributable) and OCI (consolidated) are presented at different attribution levels and cannot be reconciled directly. Implication: clear narrative disclosure does not necessarily let users trace component amounts. The contribution is a traceability status criterion that can be tried on other issuers. The study does not conclude that MEDC breaches PSAK 109 or PSAK 107.
No takes yet. Share an insight, caveat, or question.
Ghifari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: